LumiusSpring 2026Active☆Watch⊞Compare

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

Fast, smart, accessible 3D ultrasound that anyone can use

Ultrasound today is still mostly 2D. Clinicians have to imagine the 3D anatomy in their head while also moving the probe at the same time. This makes procedures like vascular access hard to learn and perform consistently, especially for beginners. ~50% fail on their first attempt. Hospitals also spend millions each year on 2D ultrasound training. Meanwhile, existing 3D ultrasound devices can cost >10× as much. Lumius is building fast, smart, and accessible 3D ultrasound systems to eliminate this 2D guesswork. Our technology shows a clear, real-time 3D view of what’s inside the body. It works over a large volume, not just a thin slice. The device is also affordable, compact, and portable. We are starting with vascular access, especially central line. Future use cases include blood clot detection, tumor diagnosis, and biopsy guidance. Our long-term vision is a universal 3D ultrasound platform that brings easy-to-use, real-time imaging to a wide range of clinical and eventually consumer applications.

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

No staged rounds to sequence.

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Benchmarked against 8525 companies in this sector. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 96% of sector peers (real $). Modeled value above 96% of peers (estimate).

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Lumius is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where Lumius sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at Lumius, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.